Ezrin (EZR) Rabbit Polyclonal Antibody

CAT#: TA310007

Rabbit anti-EZR (Ezrin, Phospho-Thr566) polyclonal antibody(Phospho-specific)



Need it in bulk or conjugated?
Get a free quote

CNY 6,193.00


货期*
7周

规格
    • 100 ug

Product images

经常一起买 (5)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Recombinant protein of human ezrin (EZR), transcript variant 1, 20 µg
    • 20 ug

CNY 2,900.00
CNY 6,650.00


Transient overexpression lysate of ezrin (EZR), transcript variant 2
    • 100 ug

CNY 3,080.00


Recombinant protein of human ezrin (EZR), transcript variant 1, 100 µg
    • 100 ug

CNY 9,998.00


Transient overexpression lysate of ezrin (EZR), transcript variant 1
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Applications WB
Recommend Dilution WB: 1:500~1:1000
Reactivity Human, Mouse, Rat
Modifications Phospho-specific
Host Rabbit
Clonality Polyclonal
Immunogen The antiserum was produced against synthesized phosphopeptide derived from humanEzrin around the phosphorylation site of tyrosine 566 (Y-K-TP-L-R).
Formulation phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration lot specific
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Gene Name ezrin
Synonyms CVIL; CVL; HEL-S-105; VIL2
Reference Data
Protein Families Druggable Genome
Protein Pathways Leukocyte transendothelial migration, Pathogenic Escherichia coli infection, Regulation of actin cytoskeleton
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...